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Adult hippocampal neurogenesis results in the continuous formation of new neurons
and is a process of brain plasticity involved in learning and memory. Although inducible-
reversible transgenic mouse models are increasingly being used to investigate adult
neurogenesis, transgene control requires the administration of an activator, doxycycline
(Dox), with unknown effects on adult neurogenesis. Here, we tested the effect of
Dox administration on adult neurogenesis in vivo. We found that 4 weeks of Dox
treatment at doses commonly used for gene expression control, resulted in increased
neurogenesis. Furthermore, the dendrites of new neurons displayed increased spine
density. Concomitantly, Iba1-expressing microglia was reduced by Dox treatment. These
results indicate that Dox treatment may interfere with parameters of relevance for the use
of inducible transgenic mice in studies of adult neurogenesis or brain inflammation.
Keywords: dentate gyrus, hippocampus, adult neurogenesis, doxycycline, tetracycline, gene expression regulation
INTRODUCTION
Adult neurogenesis occurs mainly in two discrete areas: the
olfactory bulb and the dentate gyrus (DG) of the hippocampus
(Altman, 1969). The process of adult neurogenesis consists in sev-
eral steps: First, the division of adult neural stem cells, residing in
the subgranular zone (SGZ) of the DG (Gage, 2000). Adult neural
stem cells display a radial glia like (RGL) morphology, character-
ized by a unique radial process extending through the granule cell
layer and branching into the molecular layer and by the expres-
sion of several markers such as the astrocytic glial fibrillary acidic
protein (GFAP) and nestin (Huttmann et al., 2003; Ehninger
and Kempermann, 2008). RGL cells divide asymmetrically to
self-renew and yield highly proliferative transit-amplifying pro-
genitors (TAPs), which do not have a radial morphology and
express nestin and the T-box brain gene 2 (Tbr2), but not GFAP.
TAPs give rise to immature neurons, which express the imma-
ture neuronal marker doublecortin (DCX) and differentiate into
mature, NeuN-expressing neurons (Gage, 2000; Ma et al., 2009;
Yao et al., 2012). During their maturation, young neurons project
their dendrites into the molecular layer, form dendritic spines,
which receive synaptic inputs from perforant path afferences from
the entorhinal cortex (Gage, 2000; Van Praag et al., 2002; Laplagne
et al., 2006; Toni et al., 2007; Toni and Sultan, 2011). They also
project their axons to the hippocampal CA3 area and establish
synaptic connections with postsynaptic inhibitory interneurons
and excitatory pyramidal neurons (Toni et al., 2008). After 8
weeks, new neurons are morphologically and functionally indis-
tinguishable from neighboring neurons and are completely inte-
grated into the hippocampal network (Laplagne et al., 2006; Ge
et al., 2008).
The mechanisms regulating adult neurogenesis are highly rel-
evant for our understanding of brain plasticity and for the poten-
tial use of these cells as therapeutic targets. Indeed, although their
role remains unclear, increasing evidence suggests that new neu-
rons are involved in mechanisms of learning and memory (Van
Praag et al., 1999, 2002; Saxe et al., 2006, 2007; Dupret et al.,
2007; Trouche et al., 2009; Massa et al., 2011; Gu et al., 2012;
Shors et al., 2012; Tronel et al., 2012) as well as in depression
and mood control (Santarelli et al., 2003; Samuels and Hen,
2011). However, one of the great difficulties in studying adult
neurogenesis in vivo, is that the mechanisms regulating neuronal
proliferation, differentiation and survival also play a role dur-
ing brain development and therefore, their manipulation leads
to prenatal death or morbidity. This experimental caveat can be
circumvented by the use of inducible transgene expression, such
as the tetracycline regulatory system, controlled with the admin-
istration of doxycycline (Dox) (Gossen and Bujard, 1992; Zhou
et al., 2006; Chow et al., 2012). This elegant system enables the
bi-directional and non-invasive regulation of gene expression.
Furthermore, by controlling the timing of the genetic manipula-
tion, genes necessary for cell survival can be manipulated with-
out affecting brain development. However, although inducible
transgenic mouse models are increasingly being used for studies
of adult neurogenesis, the effect of Dox on adult neurogene-
sis is unknown. Dox is a synthetic antibiotic of the tetracycline
inhibitors group, with reported effects on pain, inflammation and
neuroprotection (Clark et al., 1997; Cho et al., 2009; Jantzie and
Todd, 2010; Yoon et al., 2012). Thus, the use of Dox to control
gene expression may potentially bias phenotypic analysis of adult
neurogenesis with the introduction of confounding factors.
The aim of the present study was to examine the poten-
tial effects of Dox on adult neurogenesis in vivo. We have used
a per os administration route, which corresponds to the main
experimental protocol for the control of transgene expression.
Using immunohistochemistry and viral-mediated labeling, we
have analyzed the effect of Dox on RGL cells, TAPs and on the
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differentiation, survival and synaptic maturation of new neurons,
as well as on microglia.
MATERIALS ANDMETHODS
ETHICS STATEMENT
This study was carried out in strict accordance with the recom-
mendations in the Guidance for the Care and Use of Laboratory
Animals of the National Institutes of Health. All experimental
protocols were approved by the Swiss animal experimentation
authorities (Service de la consommation et des affaires vétéri-
naires, Chemin des Boveresses 155, 1066 Epalinges, Switzerland,
permit number: 2301). Every effort was made to minimize the
number of animals used and their suffering.
EXPERIMENTAL ANIMALS
Animals used for the study were adult males of 6 weeks of age
at the beginning of the experiment. All animals were housed in
standard cages under a 12-h light/dark cycle and temperature-
controlled (22◦C) conditions. Food and water were available ad
libitum. C57Bl/6 mice were purchased from Janvier (le Genest
Saint Isle, France), GFAP-GFP mice were a kind gift from the
laboratory of Helmut Kettenmann (Max-Delbruck center, Berlin,
Germany) (Nolte et al., 2001). They express the green fluores-
cent protein (GFP) under the control of the astrocyte-specific
human GFAP promoter. Nestin-GFP mice were a kind gift from
the laboratory of K. Mori (PRESTO, Kyoto, Japan) (Yamaguchi
et al., 2000). They express GFP under the control of the stem
cell-specific promoter nestin. Food pellets containing 40-ppm of
Dox were purchased fromHarlan Laboratory (WI, USA). Control
mice were fed with the same food pellets without Dox, purchased
from the same source.
BrdU ADMINISTRATION
Bromodeoxyuridine (BrdU, Sigma-Aldrich, Buchs, Switzerland)
was injected intraperitoneally at doses of 100mg/kg in saline, 3
times at 2-h intervals. Mice were then sacrificed either 2 h after
the last injection, to examine cell proliferation (Mandyam et al.,
2007; Taupin, 2007; Yang et al., 2011; Gao and Chen, 2013) or 30
days after injections, to examine newborn cells survival (Taupin,
2007).
RETROVIRUS-MEDIATED LABELING
We used a retroviral vector derived from the Moloney murine
leukemia virus (MoMuLv) containing a GFP-expression cassette
under the control of the cytomegalovirus early enhancer and
chicken beta-actin promoter (cag) (Zhao et al., 2006). The final
virus titer was 10E8 pfu/ml, as measured by GFP–expressing
colony formation on 293T cells. Mice were anesthetized with
a mixture of 90mg/kg ketamine and 4.5mg/kg xylazine (i.p.)
and then placed in a stereotaxic instrument (Narishige Scientific
Instruments, Tokyo, Japan). 1.5µl of virus was injected bilaterally
at the following coordinates from the Bregma: anteroposterior
−2mm, lateral 1.75mm and dorsoventral −2.25mm. GFP signal
was amplified by immunohistochemistry using chicken anti-
GFP IgY (AnaSpec Inc. CA 94555, 1:1000) and dylight 488 goat
anti-chicken IgY (Jackson ImmunoResearch Europe ltd., Suffolk,
United Kingdom; 1:250).
TISSUE COLLECTION AND PREPARATION
Mice were deeply anesthetized with a lethal dose of pentobarbital
(10mL/kg, Sigma-Aldrich, Buchs, Switzerland) and perfusion-
fixed with 50ml of 0.9% saline immediately followed by 100mL
of 4% paraformaldehyde (Sigma-Aldrich, Switzerland) dissolved
in phosphate buffer saline (PBS 0.1 M, pH 7.4). Brains were then
dissected, post-fixed overnight at 4◦C, cryoprotected 24 h in 30%
sucrose and rapidly frozen. Coronal frozen sections of a thick-
ness of 40µm were cut with a microtome-cryostat (Leica MC
3050S) and slices were stored in cryoprotectant (30% ethylene
glycol and 25% glycerin in 1X PBS) at −20◦C until processing for
immunostaining, as described previously (Thuret et al., 2009).
IMMUNOHISTOCHEMISTRY
Sections were washed 3 times in PBS 0.1M. BrdU detection
required formic acid pretreatment (formamide 50% in 2× SSC
buffer; 2× SSC is 0.3M NaCl, and 0.03M sodium citrate, pH 7.0)
at 65◦c for 2 h followed by DNA denaturation for 30min in 2M
HCl at 37◦C and rinsed in 0.1M borate buffer pH 8.5 for 10min.
Nonspecific binding was blocked with 0.25% Triton-X100 and
15% normal serum [normal goat serum (Gibco, 16210-064) or
normal donkey serum (Sigma Aldrich, D-9663), depending on
the secondary antibody] in PBS 0.1M. Slices were then incubated
48 h at 4◦C with the primary antibodies described below. Then
sections were incubated for 2 h with the corresponding secondary
antibodies in PBS 0.1M. 4,6 diamidino-2-phenylindole (DAPI)
was used to reveal nuclei.
Primary antibodies used for immunohistochemistry were as
follows: rabbit anti-Ki-67 (1:200, Abcam, ab15580), goat anti-
DCX (1:500, Santa Cruz biotechnology, sc-8066), rabbit anti-
Tbr2 (1:200, Abcam, ab23345), mouse monoclonal anti-BrdU
(1:250, Chemicon International, Dietikon, Switzerland), mouse
anti-NeuN (Chemicon international 1:1000), goat anti-Iba1
(1:200, Abcam, ab5076), rabbit anti-GFAP (1:500, Invitrogen,
180063).
Secondary antibodies were used as follows: goat anti-mouse
Alexa-594 (1:250, Invitrogen), goat anti-rabbit Alexa-594 (1:250,
Invitrogen), goat anti-rabbit Alexa-488 (1:250, Invitrogen), don-
key anti-goat Alexa-555 (1:250, Invitrogen).
IMAGE ANALYSIS
All images were acquired using a confocal microscope (Zeiss LSM
710 Quasar Carl Zeiss, Oberkochen, Germany). The total num-
bers of immunoreactive cells throughout the entire granule cell
layer were estimated using stereological sampling, as previously
described (Thuret et al., 2009), between −1.3 and −2.9mm from
the Bregma. However, no guard zones were used, which may lead
to possible bias in the counting of cells at the edge of each section,
spread across control and Dox groups. For each animal, a 1-in-
6 series of sections was stained with the nucleus marker DAPI
and used to measure the volume of the granule cell layer. The
granule cell area was traced using Axiovision (Zeiss, Germany)
software and the granule cell volume was determined by mul-
tiplying the traced granule cell layer area by the thickness of
the corresponding section and the distance between the sections
sampled (240µm). For all mice analyzed in this study, no dif-
ference was found between Dox-treated and control animals. All
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cells were counted blind with regard to the mouse status. Cells
were counted in the entire thickness of the sections in a 1-in-6
series of section (240µm apart) with a 40× objective. The num-
ber of immunolabeled cells was then related to granule cell layer
sectional volume and multiplied by the reference volume to esti-
mate the total number of immunolabeled cells. Cells expressing
BrdU, Ki-67, DCX or Tbr2 were counted in the granule cell layer,
whereas cells expressing Iba1 and GFAP (Figure 6) were counted
in the whole DG.
BrdU colocalization with the neuronal marker NeuN was ana-
lyzed by confocal microscopy and was confirmed on single optical
sections, for 50–60 cells per animal. The proportion of double-
labeled cells was then obtained for each animal and then averaged
for each group. DCX-expressing cells were counted on confocal
stack images using the colocalization with the nuclear stain DAPI
and/or the presence of processes as visual landmarks for their
identification. This approachmay lead to a slight underestimation
of DCX-expressing cell numbers. Spine density was assessed as
previously described (Krzisch et al., 2013). Dendrites were imaged
with confocal microscopy in the second third of the molecular
layer and their length as well as spine density (number of spines
divided by dendritic length) wasmeasured using image J software,
for 40–50 neurons per group.
Spine morphology was classified in three groups based on
the maximal diameter of the spine head, as measured on maxi-
mal projections with Image J software: Filopodia <0.25µm, thin
spines 0.25–0.45µm and mushroom spines >0.45µm. The per-
centage of each type of dendritic spine was then expressed by
neuron and averaged for each mouse (25–30 neurons per group,
800 spines per group).
CELL CULTURE
Adult neural progenitor cells (NPC) expressing the red fluores-
cent protein (RFP) are a kind gift from the laboratory of Fred
Gage (Salk Institute, San Diego, USA). They were originally iso-
lated from the DG of adult Fisher 344 rats and cultured as
previously described (Palmer et al., 1997).
Microglia and astrocyte primary culture were purified from
postnatal day 2 rats. Cerebral cortices were mechanically tritu-
rated for homogenization and seeded onto poly-D-lysine coated
75 cm2 flasks in Dulbecco’s Modified Eagle Medium (DMEM)
glutamax (Invitrogen, USA), 10% normal calf serum with peni-
cillin/streptomycin (Invitrogen, USA). Cells were grown for 5–7
days in a humidified 5% CO2 incubator at 37◦C. At conflu-
ence, flasks were shaken at 250 rpm on an orbital shaker for
2 h to separate microglia from astrocytes. Detached microglia
were seeded in poly-D-lysine coated 6-well microplates in cul-
ture medium supplemented with 30% astrocyte conditioned
medium.
All three cell types were cultured separately and, one day after
plating, were treated with Dox or vehicle (PBS). Dox was pur-
chased from Sigma-Aldrich (St Louis, MO, USA) and dissolved in
PBS to prepare a stock solution of 10mg/ml. The stock solution
was stored at −20◦C. Upon use, the stock solution was diluted
10 times in PBS and 1µl of the solution was added daily to
the culture medium, at a concentration of 1µg/ml. This regi-
men of Dox treatment is commonly used for the induction of
tetracycline-dependent gene expression in cell culture (Stegmeier
et al., 2005; Richter et al., 2013).
After the treatment, cells were fixed and mounted for cell
quantification. The number of Iba1+, RFP+, and GFAP+ cells
was counted in twelve randomly selected fields per condition
(three culture wells per groups, four fields per culture well) on
confocal micrographs. The number of cells was then divided by
the surface area of the selected fields, to obtain cell density. The
density was then averaged between the four fields to obtain the
average density per culture well.
STATISTICAL ANALYSIS
Hypothesis testing was two-tailed. All analyses were performed
using JMP10 software. First, Shapiro-Wilk tests were performed
on each group of data to test for distribution normality. The
distribution was normal for all data. For two-sample compar-
isons, the equality of variances of the groups was tested and the
adequate unpaired t-test was used. For the analysis of dendritic
spine morphology (Figure 5C), parametric tests were used (two-
way ANOVA followed by a post-hoc Student’s t-test). Data are
presented as mean ± SEM.
RESULTS
Dox EXPOSURE INCREASED CELL PROLIFERATION
To examine the effect of Dox treatment on cell proliferation, 6
weeks old C57Bl/6 mice were fed for 4 weeks with unlimited sup-
ply of food pellets containing either 40 ppm of Dox or no Dox
(Figure 1A). At the end of the treatment, mice were sacrificed and
brain slices were immunostained for the proliferation marker Ki-
67 (Kee et al., 2002). Treated animals showed a higher number of
Ki-67 labeled cells in the granule cell layer of the DG than con-
trol mice (Figures 1B,C, Student’s t- test, p < 0.001) suggesting
an increased number of cells in the cell cycle.
We next examined the effect of Dox treatment on immature
neurons expressing DCX. Dox treatment significantly increased
the number of immature neurons (Figures 1D,E, Student’s t-
test, p < 0.001). Thus, Dox treatment enhanced proliferation in
the adult hippocampus and increased the number of immature
neurons. To test whether the increased number of Ki-67- and
DCX-expressing cells could be caused by a change in hippocam-
pal volume upon Dox treatment, we measured the volume of
the granule cell layer of all mice. We did not detect a differ-
ence between treated and untreated animals (0.16 ± 0.05mm3
vs. 0.15 ± 0.01mm3, respectively, n = 5 and Student’s t-test, p =
0.7), indicating that the increased number of Ki-67 and DCX-
immunolabeled cells reflected an increase in proliferation.
We then investigated the effect of Dox on the twomain types of
proliferative cells: RGL cells and TAPs. RGL cells were identified
using nestin-GFP (Figures 2A,B) and GFAP-GFP (Figures 2C,D)
mice, which are commonly used mouse models in studies of
adult neurogenesis (Huttmann et al., 2003; Mignone et al.,
2004; Beckervordersandforth et al., 2010). In both mouse lines,
RGL cells are readily identifiable by their specific morphology
(Kriegstein and Alvarez-Buylla, 2009), consisting of a nucleus
in the SGZ and a large process extending through the gran-
ule cell layer and branching into the proximal molecular layer
(Figures 2B,D, insets). With immunostaining, we confirmed that
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FIGURE 1 | Dox effect on cell proliferation. (A) Experimental timeline:
C57Bl/6 mice were treated with control food (Ctrl.) or food containing Dox
for 4 weeks and sacrificed at 10 weeks of age. (B) Histogram showing the
number of Ki-67–expressing cells in the dentate gyrus. Animals: n = 5 per
group. (C) Confocal micrographs of hippocampal sections immunostained
with Ki-67 in control animals (upper panel), and treated animals (lower
panel). Inset: Higher magnification confocal micrograph of a
Ki-67-expressing cell. (D) Histogram showing the number of doublecortin
(DCX)-immunolabeled cells in the dentate gyrus. Animals: n = 5 per group.
(E) Confocal micrographs of hippocampal sections immunostained for DCX
from control animals (upper panel), and treated animals (lower panel). Inset:
Higher magnification confocal micrograph of a DCX-immunolabeled group
of cells. Blue: Dapi staining. Scale bars: 100µm, insets 10µm, ∗∗∗p < 0.001
bilateral Student’s t-test. Each value represents the mean ± SEM.
these cells expressed nestin, GFAP, and sox-2 (data not shown).
Surprisingly, Dox treatment significantly reduced the number of
RGL cells in both the nestin-GFP mice (Figure 2A, Student’s t-
test, p < 0.001) and the GFAP-GFP mice (Figure 2C, Student’s
t-test, p < 0.001).
TAPs were identified using immunostaining against Tbr2,
(Hodge et al., 2008, Figure 3). In untreated nestin-GFP mice,
94.5 ± 1% of TbR2 + cells co-labeled with GFP (n = 100 Tbr2+
cells), but 93.1 ± 2% of them did not have RGL morphology
(Figure 3C). Dox treatment significantly increased the number
of Tbr2-expressing cells (Figure 3A, Student’s t-test, p < 0.001).
Here too, we did not detect any difference in the volume of
the granule cell layer between treated and control animals in
both nestin-GFP treated and untreated animals (1.4 ± 0.09mm3
vs. 1.51 ± 0.06mm3, respectively, n = 4 and Student’s t-test,
p = 0.63) and treated and untreated GFAP-GFP mice (1.43 ±
0.04mm3 vs. 1.43 ± 0.01mm3, respectively, n = 4 and Student’s
t-test, p = 0.97).
FIGURE 2 | Dox effect on the number of RGL cells in the dentate gyrus.
(A) Histogram showing the number of RGL cells in the dentate gyrus of
nestin-GFP mice exposed to control (Ctrl.) or Dox treatment. (B) Confocal
micrographs of hippocampal sections from control (upper panel) and
treated animals (lower panel). Inset: higher magnification confocal
micrograph of a RGL cell. (C) Histogram showing the number of RGL cells
in the dentate gyrus of GFAP-GFP mice exposed to control (Ctrl.) or Dox
treatment. (D) Confocal micrographs of hippocampal sections from control
(upper panel) and treated animals (lower panel). Inset: higher magnification
confocal micrograph of a RGL cell. Blue: Dapi staining. Animals: n = 4 per
group, scale bars: 100µm, insets 10µm, ∗∗∗p < 0.001 bilateral Student’s
t-test. Each value represents the mean ± SEM.
Thus, Dox treatment increased the total number of the highly-
proliferative progenitors, but decreased the number of the quies-
cent, slowly-proliferative RGL cells.
Dox TREATMENT INCREASED ADULT NEUROGENESIS
To examine the effect of Dox treatment on the fate of new-
born cells, two groups of adult C57Bl/6 mice were treated with
Dox during 4 weeks, after which they received three injections of
BrdU (intraperitoneal, 1.0mg/kg in saline at 2 h intervals). One
group of mice was sacrificed 2 h after the last injection, while
the second group received another 4 weeks of Dox treatment
and was analyzed thereafter to assess neuronal differentiation
(Figure 4A). The first group showed a higher number of BrdU-
expressing cells in the DG as compared to control-treated mice
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FIGURE 3 | Dox effect on the number of progenitors. (A) Histogram
showing the number of Tbr2-expressing cells in the dentate gyrus of
nestin-GFP mice exposed to control food (Ctrl.) or Dox treatment. (B)
Confocal micrographs of hippocampal sections immunostained for Tbr2
from control (upper panel) and treated animals (lower panel) scale bars:
100µm, inset 10µm. (C) Left panel: Confocal micrograph of a hippocampal
section (maximum projection) from a nestin-GFP mouse immunostained for
Tbr2 (red) scale bar: 50µm Right panel: Orthogonal projection of a
Tbr2-immunolabeled cell also expressing GFP. Scale bar: 15µm. Blue: Dapi
staining. Animals: n = 4 per group, ∗∗∗p < 0.001 bilateral Student’s t-test.
Each value represents the mean ± SEM.
(Figure 4B, Student’s t-test, p < 0.01), supporting our previous
observation of increased cell proliferation with Dox treatment
(Figure 1). Similarly, in the second group (4 weeks after the
last BrdU injection), the number of BrdU-expressing cells was
higher in Dox-treated mice than in control mice (Figure 4C,
Student’s t-test p < 0.001). Finally, we assessed the neuronal
differentiation of BrdU-labeled cells into neuronal lineage, by
co-labeling for BrdU and the neuron-specific marker, NeuN
(Figure 4E). In control mice, neurons accounted for 83 ± 0.2%
of the surviving BrdU-positive cells as compared to 84 ± 0.3%
in Dox-treated mice (Student’s t-test p > 0.05), indicating that
differentiation was not affected by Dox treatment. All together,
these results indicate that Dox-treated mice generate 43.4 ± 0.4%
more neurons than non-treated mice (Figure 4D, Student’s t-test,
p < 0.001).
Dox TREATMENT INCREASED SPINE DENSITY ON NEWBORN
NEURONS
The final stage of neurogenesis consists in the integration of the
newly-formed neurons into the hippocampal excitatory circuitry
FIGURE 4 | Effect of Dox on the number of new neurons. (A)
Experimental timeline: 6 weeks old C57Bl/6 mice were treated with
control food (Ctrl.) or food containing Dox for 4 weeks and received
BrdU injections. The first group of mice was euthanized 2 h after the
BrdU injections to assess the number of proliferative BrdU+ cells. The
second group received another 4 weeks of Dox treatment, after which
they were euthanized, to measure the number of surviving newborn
cells. (B) and (C) Histogram showing the number of BrdU-expressing
cells in the dentate gyrus of animals exposed to control (Ctrl.) or Dox
food, the day of injection (B) or 4 weeks after BrdU injections (C).
Animals: n = 5 per group. (D) Histogram showing the quantification of
cells expressing NeuN relative to the number of BrdU-positive cells, 4
weeks after the last BrdU injection. (E) Left: confocal micrographs of
hippocampal sections immunostained for BrdU (red) and NeuN (green) in
control animals (upper panel) and treated animals (lower panel) scale bar:
100µm. Right: Higher magnification confocal micrographs of a
BrdU-NeuN expressing cells. Scale bar: 10µm, inset 10µm. Animals:
n = 3 per group, 48–69 cells per animal. ∗∗p < 0.01, ∗∗∗p < 0.001 bilateral
Student’s t-test. Each value represents the mean ± SEM.
and is commonly assessed by measuring dendritic spine den-
sity. To this aim, new neurons were identified by viral-mediated
gene transfer, with the use of a MoMuLV containing the expres-
sion cassette for GFP. C57Bl/6 mice were treated with Dox for
4 weeks and then stereotaxically injected with GFP-retrovirus,
followed by 4 weeks of Dox treatment (Figure 5A). Dendritic
spines were analyzed in the middle-third of the molecular
layer, where inputs arise mainly from the entorhinal cortex.
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At 30 days post-virus infection, Dox treatment increased spine
density (Figures 5B,D,E, Student’s t-test, p < 0.001). Dendritic
spine diameter increases with neuronal maturation (Zhao et al.,
2006; Toni et al., 2007) and reflects synaptic strength (Murthy
et al., 2001). To examine the effect of Dox on dendritic spine
maturation, we classified dendritic spines in three categories,
based on the maximal diameter of the spine head: filopo-
dia spines <0.25µm, thin spines 0.25–0.45µm and mushroom
spines >0.45µm. Dox treatment did not change the propor-
tion of filopodia, thin and mushroom spines [Figure 5C, two
way ANOVA F(2, 108) = 1.1, p = 0.33], indicating that this treat-
ment increased spine density but did not affect dendritic spine
morphology.
Dox REDUCED MICROGLIA BUT NOT ASTROGLIA in vivo AND in vitro
Dox is a member of the tetracycline antibiotics group and its
analog, minocycline, has been reported to decrease microglia
and inhibit microglia activation (Ng et al., 2012). We therefore
FIGURE 5 | Effect of Dox on the spine density of newborn neurons. (A)
Experimental timeline: C57Bl/6 mice were treated with control food (Ctrl.)
or food containing Dox for 4 weeks before viral injection. Dox treatment
was continued for 4 weeks after viral injection. (B) Histogram showing the
spine density on newborn neurons from the two experimental conditions,
n = 48–54 neurons per group, ∗∗∗p < 0.001 bilateral Student’s t-test. (C)
Histogram showing the percentage of filopodia (Fil.), thin spines (Th.), and
mushroom spines (Mu.) on newborn neurons from control-treated animals
(black) and Dox-treated animals (gray) n = 838–895 spines per group. (D)
Confocal micrographs of hippocampal sections of retrovirally-injected mice
from control animals (upper panel) and treated animals (lower panel) Blue:
Dapi staining, scale bar: 100µm. (E) Confocal micrographs of spiny
dendrites from control animals (upper panel) and treated animals (lower
panel) scale bars: 10µm. Each value represents the mean ± SEM.
analyzed the effect of Dox onmicroglia, identified with immunos-
taining for the microglia-specific marker Iba1. Four weeks of Dox
treatment significantly decreased the number of Iba1-expressing
cells in the hippocampus (Figures 6A,B, Student’s t-test, p <
0.001). In contrast, the number of astrocytes, identified with
immunohistochemistry for GFAP, was not affected by Dox treat-
ment (Figures 6C,D, Student’s t-test, p = 0.59), indicating that
the effect of Dox was specific to microglia. To test the effect of Dox
directly onmicroglia, we performed in vitro experiments on puri-
fied cell cultures. Microglia was treated with either 1µg/ml Dox
or the equivalent volume of PBS 0.1M. After 8 days, cells were
fixed and immunostained for Iba1. Dox treatment reduced the
density of microglia (Figures 7A,B, Student’s t-test, p < 0.01). In
contrast, the same treatment did not have any effect on purified
astrocytes identified with GFAP immunostaining (Figures 7C,D,
Student’s t-test, p = 0.2) or on NPC (Figures 7E,F, Student’s
t-test, p = 0.26). Thus, Dox treatment reduced microglia both
in vivo and in vitro.
FIGURE 6 | Effect of Dox on the number of microglia and astrocytes in
the dentate gyrus. (A) Histogram showing the number of Iba1-expressing
cells in the dentate gyrus of mice exposed to control food (Ctrl.) or Dox
treatment. Animals: n = 5 per group, ∗∗∗p < 0.001 bilateral Student’s t-test.
(B) Confocal micrographs of hippocampal sections immunostained for Iba1
from control animals (upper panel), and treated animals (lower panel). Inset:
Higher magnification confocal micrograph of an Iba1-immunolabeled cell.
(C) Histogram of the number of GFAP-expressing astrocytes in the dentate
gyrus of mice for each experimental condition. Animals: n = 3 per group.
(D) Confocal micrographs of hippocampal sections immunostained for
GFAP from control animals (upper panel), and treated animals (lower panel).
Inset: Higher magnification confocal micrograph of a GFAP-immunolabeled
cell. Blue: Dapi staining. Scale bars: 100µm, insets 10µm. N.S: p > 0.05.
Each value represents the mean ± SEM.
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FIGURE 7 | Effect of Dox on microglia, astrocytes and progenitor
cells in vitro. (A) Histogram of the density (×10−5 cells/µm2), of
Iba1-expressing cells after vehicle (Ctrl.) or Dox treatment of purified
microglia cultures. ∗∗p < 0.01 bilateral Student’s t-test. (B) Confocal
micrographs of Iba1-immunostained cultures for control (upper panel)
and treated condition (lower panel). (C) Histogram of the density
(×10−4 cells/µm2), of GFAP-expressing cells of purified cultures treated
for each condition. (D) Confocal micrographs of GFAP-immunostained
cells for control (upper panel) and treated condition (lower panel). (E)
Histogram of the density (×10−3 cells/µm2), of purified NPC for each
condition. (F) Confocal micrographs of RFP-expressing NPC for control
(upper panel) and treated condition (lower panel). n = 3 culture wells
per group. Scale bar: 100µm. N.S: p > 0.05. Each value represents
the mean ± SEM.
DISCUSSION
In this study, we tested the effect on adult neurogenesis of a
Dox treatment commonly used to regulate gene expression in
inducible transgenic mice. Dox reduced the number of RGL cells
but increased the number of TAPs in the DG of adult mice. This
may result from a shift in fate choice of the RGL cells leading to a
depletion of the RGL cells pool in favor of the highly proliferative
TAPs (Encinas et al., 2011), a possibility which may be further
tested by examining the expression of the proliferation marker
Ki-67 and self-renewal transcription factor sox2 in RGL cells of
both groups. As a consequence, Dox treatment increased cell pro-
liferation and resulted in a net increase in neurogenesis. Although
cell counts were performed without the use of guard zones, which
may lead to possible bias in the counting of cells at the edge of
each section, this bias was spread across both groups and may
affect the absolute number of cells, but not the intergroup dif-
ference. In addition, Dox increased dendritic protrusions density
on the neurons formed during the treatment. Concomitantly,
microglia but not astrocytes were reduced by Dox. These results
indicate that Dox has multiple effects on adult neurogenesis.
Although the mechanism of action of Dox is unclear, the dra-
matic reduction of microglia in vitro and in vivo, and the lack of
effect of Dox on astrocytes and NPC in vitro, raises the possibility
that the effect of this drug on adult neurogenesis may be medi-
ated by microglia. In support of this possibility, inflammatory
microglia inhibit adult neurogenesis (Monje et al., 2002; Ekdahl
et al., 2003; Liu et al., 2007; Kohman et al., 2012) and the exercise-
induced increase and the age-dependent decline in neurogenesis
are mediated by microglia, possibly through CX3CR1-receptor
activity (Vukovic et al., 2012). Furthermore, Dox and its ana-
log minocycline have been shown to inhibit inflammation in
models of ischemia, brain trauma, pain or neurodegenerative dis-
eases (Yrjanheikki et al., 1998; Thomas et al., 2003; Buller et al.,
2009; Kim and Suh, 2009; Jantzie and Todd, 2010; Lu et al.,
2010; Wideroe et al., 2012; Kobayashi et al., 2013). Accordingly,
minocycline decrease microglia number and increase adult neu-
rogenesis (Kohman et al., 2013). Thus, an extensive reduction in
microglia, such as observed with Dox treatment, may interfere
with adult neurogenesis. However, the effects of Dox onmicroglia
and neurogenesis may be unrelated and further experiments will
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be necessary to examine the causality between reduced microglia
and increased neurogenesis upon Dox treatment.
In addition to its effect on microglia, Dox is known to also
inhibit Matrix Metalloproteinases (MMPs) (Burggraf et al., 2007;
Lee et al., 2009). MMPs are soluble or membrane-bound pro-
teases capable of degrading cell-surface receptors and extracellu-
lar matrix proteins, which play a role in tissue remodeling and
receptor activation. MMPs are involved in several aspects of neu-
rogenesis: MMP-17 prevents neurogenesis by shedding the ligand
for, and activating EGFR (Epidermal growth factor receptor) and
its inhibition results in increased neurogenesis (Romero-Grimaldi
et al., 2011). MMP-3 and MMP-9 promote the differentiation
and migration of neural progenitors (Barkho et al., 2008). Also,
MMPs are involved in synaptic plasticity (Bozdagi et al., 2007)
and synaptogenesis (Ethell and Ethell, 2007) by the cleavage of
trans-synaptic adhesion molecules (Huntley, 2012; Peixoto et al.,
2012) and the inhibition of MMP-9 inhibits the LTP-induced
spine enlargement and stabilization (Wang et al., 2008). Finally,
MMPs are involved in inflammation and the genetic deletion of
MMP-9 results in decreased inflammation and neuroprotection
in a mouse model of hypoxia (Svedin et al., 2007). Thus, the inhi-
bition of MMPs by Dox may result in increased neurogenesis.
However, the involvement of MMPs or microglia on the Dox-
mediated increase in neurogenesis remains unclear and additional
experiments may elucidate the mode of action of Dox.
Together, our observations indicate that Dox decreased
microglia and increased adult neurogenesis, a combination of
effects that can introduce confounding factors in studies of adult
neurogenesis or brain inflammation. Together with the recent
observation that Dox reduced alcohol consumption in mice and
increased the sensitivity to alcohol-induced motor impairment
(McIver et al., 2012), the present study suggests that, at doses
necessary for the induction of gene expression in transgenic
mice with tetracycline-responsive promoters, Dox has multiple
effects on the central nervous system. Further experiments will
be needed to determine whether shorter Dox treatments or other
routes of administration, such as intraperitoneal injections, or
administration in water induce similar effects on adult neuro-
genesis and microglia. However, the best experimental design to
circumvent the caveats of using tetracycline-responsive promot-
ers relies on the appropriate use of Tet-on or Tet-off systems
to enable the experimental tests to be performed in absence
of Dox. Alternatively, it is recommended that control exper-
iments include Dox-treated animals. Gene expression control
is a critical and increasingly used tool for our understanding
of brain physiology and future developments will enable the
use of this technology with more specific approaches, thereby
reducing confounding factors. In this perspective, the recent
introduction of new Tet activators with enhanced sensitivity
to Dox represents an interesting effort aimed at using lower
doses of Dox, thereby reducing effects on brain physiology
(Zhou et al., 2006).
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